Chen et al. illustrated that T-complex protein 1 (TCP1) enhances drug resistance in AML by inhibiting autophagy and apoptosis triggered by Adriamycin through the activation of the AKT/mTOR signaling pathway. Here, AKT1 is linked to acute myeloid leukemia.